WO2000017185A1 - Procede de preparation de la vitamine e - Google Patents
Procede de preparation de la vitamine e Download PDFInfo
- Publication number
- WO2000017185A1 WO2000017185A1 PCT/FR1999/002196 FR9902196W WO0017185A1 WO 2000017185 A1 WO2000017185 A1 WO 2000017185A1 FR 9902196 W FR9902196 W FR 9902196W WO 0017185 A1 WO0017185 A1 WO 0017185A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- water
- solvent
- mol
- reaction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
Definitions
- the present invention relates to a new process for the preparation of vitamin E. It relates more particularly to a new process for the condensation of trimethylhydroquinone and isophytol.
- the maximum amount of water which can be used without harming the yield of the reaction and without distilling the water formed during the reaction is limited to 1.5 moles of water per mole of isophytol. Under these conditions, the influence of the amount of zinc chloride used has not been studied.
- the present invention has overcome this problem and has made it possible to condensing the TMHQ with isophytol in a polar solvent of the ester type and in the presence of water.
- the present invention therefore consists in carrying out the condensation of a phytol with trimethylhydroquinone in a polar solvent of the ester type and in the presence of a Brônsted acid and a zinc halide characterized in that the reaction is carried out in the presence of 'an amount of water between 0.7 mol eq and 2 mol eq relative to the number of moles of zinc halide and in the presence of an amount of zinc halide greater than 0.3 molar equivalent relative to the phytol.
- This amount of water has many advantages:
- the phytol is chosen from isophytol or a phytyl halide such as phytyl bromide, phytyl chloride or phytyl acetate.
- the reaction is carried out in particular in the presence of an acid of
- Brônsted chosen from hydrochloric or sulfuric acid. It is preferred to use hydrochloric acid.
- the reaction is carried out in the presence of a polar solvent making it possible to dissolve the trimethylhydroquinone and the phytol used. Mention may be made, among the polar solvents which can be used, of esters, and among them ethyl, propyl, isopropyl, butyl or isobutyl acetate, acetates having a longer chain are not preferred, although they are usable, simply the viscosity of the solvent increases with the length of the chain which is not very favorable for the reaction.
- Esters of organic acids longer than acetates can also be used, in particular esters of propionic, butyric or isobutyric, valeric or isovaleric acid, but as in the case of acetates, the increase in chain length increases the viscosity of the medium which is not always favorable for the reaction. Among all these esters, it is preferred to use isopropyl acetate.
- an organic acid chosen from acetic acid, propionic acid or butyric acid. It is preferred to use the acid corresponding to the ester used as solvent. So when using an acetate it is preferred to add acetic acid.
- the amount of organic acid added corresponds to approximately 3 to 20 times the weight amount of water present in the medium.
- the catalyst used to promote condensation is chosen from zinc halides. It is preferred to use zinc chloride. It is also advantageous to use a Brônsted acid chosen from hydrochloric or sulfuric acid.
- the catalyst is used in a better way of implementing the invention in a ratio of about 0.7 to 1.2 equivalent per mole of phytol.
- the advantage of using this quantity of Lewis acid compared to the prior art which uses less of it is:
- the molar ratio between hydroquinone and phytol is preferably between 1 and 1.5, it is very preferably between 1 and 1.2.
- Brônsted acid is preferably used in a molar amount of between 4% and 16% relative to the number of moles of phytol.
- the oc tocopherol obtained is separated from the reaction medium by liquid / liquid extraction.
- the next step in the process for preparing vitamin E when it is in the form of acetate consists in carrying out the acetalization of cc tocopherol.
- This step is carried out according to a new method which consists in acetylating the oc tocopherol with acetic anhydride in the absence of any solvent, that is to say in bulk.
- the acetylation is carried out in the presence of a catalyst consisting of an inorganic acid chosen from sulfuric acid, phosphoric acid or an alkaline acetate.
- the tocopheryl acetate obtained is even lighter than the starting tocopherol. It is preferable to use a molar ratio between acetic anhydride and tocopherol between 1 and 1.8. Preferably 0.7 to 2 mol% of acid is used as the acetylation catalyst when the latter is sulfuric acid, 1 to 2 mol% when the acetylation catalyst is phosphoric acid and 5 to 10 mol% when the acetylation catalyst is sodium acetate.
- the present invention also relates to a complete process for the preparation of vitamin E from tnmethylbenzoquinone, the whole process being carried out in the same solvent which is a good solvent for tnmethylbenzoquinone, trimethylhydroquinone and phytol.
- This solvent is in particular a polar solvent, preferably an ester and most preferably isopropyl acetate.
- It consists in a first step in carrying out a hydrogenation of tnmethylbenzoquinone with a preferably supported hydrogenation catalyst chosen from palladium and platinum. It is preferred to use palladium supported on charcoal.
- the second step consists, after filtration, so as to remove the catalyst, to carry out the condensation of the trimethylhydroquinone obtained in the first step with the phytol under the conditions described above and in particular in the presence of a zinc halide, an acid Brônsted and water and especially in the presence of zinc chloride, hydrochloric acid and water.
- the catalyst is extracted with water, this aqueous phase is concentrated in particular from 80% p to 91% p ZnCI2, so as to leave only as much as possible, counting the water coming from the acid. Brônsted, two moles of water per mole of zinc halide recycled in the second step of the process.
- the organic phase is then preferably concentrated to dryness in order to remove the reaction solvent and its possible by-products, then acetylated in bulk as described above.
- the process for extracting vitamin E acetate is then carried out in a conventional manner and known to those skilled in the art.
- the medium is extracted with a solvent little or not miscible with water, then washed with an acid solution so as to hydrolyze the remaining acetic anhydride, then washed in an alkaline medium to deacetylate the acetates of TMHQ.
- the aqueous phase containing the alkaline salt of the TMHQ is isolated, this phase is acidified and the TMHQ is extracted with the reaction solvent, that is to say the ester which allows its recycling at the condensation stage. .
- the reactor is then pressurized to 2 bars of hydrogen.
- the end of the reaction is detected by the drop in the hydrogen flow rate.
- the reaction medium is degassed and then purged with nitrogen.
- the reaction medium is filtered hot under nitrogen pressure.
- a solution of 708.2 g of TMHQ in ACIP, ready to use for the condensation reaction, is obtained.
- the hydrogenation yield is 99.8%.
- a hot solution of 76 g of TMHQ in ACIP at 16% w / w ACIP is loaded with stirring into a 1 L reactor. This solution is concentrated with stirring up to 38% w / w by distillation of ACIP at 45 ° C under vacuum.
- To the suspension obtained are added 50.1 g of ZnCI2 98% w / w dissolved in 72 g of hot acetic acid then 4 g of sulfuric acid 92% w / w.
- the reaction medium is heated to 75 ° C. 162 g of isophytol 91.5% w / w are then poured in 43 min. At the end of casting, the reaction is maintained at 75 ° C for 60 min.
- Example 3 The procedure of Example 3 is identical to that of Example 2. Only the casting time changes (84 min). The parameters are shown in Table 1. Table 1: Influence of the absence of water.
- a hot solution of 76 g of TMHQ in ACIP at 16% w / w ACIP is loaded with stirring into a 1 L reactor. This solution is concentrated with stirring up to 38% w / w by distillation of ACIP at 45 ° C under vacuum.
- To the suspension obtained are added 49.8 g of ZnCl2 98% w / w dissolved in 45 g of hot acetic acid, 4.7 g of hydrochloric acid 36% w / w then 4.8 g of water.
- the reaction medium is heated to 72 ° C. 160.5 g of isophytol 92.2% w / w are then poured in 20 min. At the end of casting, the reaction is maintained at 72 ° C for 40 min.
- the residual TMHQ is recovered by acidification of the alkaline aqueous phase with H 2 SO 4 92% w / w then extraction with ACIP.
- the TMHQ solution recovered in the ACIP can be recycled into TMHQ / lsophytol condensation.
- the reaction medium is maintained at this temperature for 90 min and then rapidly cooled to 35 ° C.
- 240 g of hexane are loaded with stirring followed by 220 g of water and 9 g of H 2 SO 4 92% w / w.
- the two phases are decanted.
- the organic phase is then washed with a mixture of 100 g of water and 12g of 50% NaOH.
- the organic phase is evaporated on a rotary evaporator at 60 ° C under vacuum for 2 h.
- the aqueous phase (269.7 g) containing ZnCI2 and HCl is evaporated on a rotary evaporator under a vacuum of 5 to 10 Torrs at approximately 115 ° C until a suspension is obtained ( ⁇ 90% w / w of ZnCI2).
- To this suspension are added 45.6 g of AcOH to obtain a solution.
- the exact title in ZnCI2 is dosed by colorimetry.
- This ZnCl2 solution is used in the following TMHQ / lsophytol condensation reaction where the additional water charge is no longer necessary.
- the quantities of reagents are calculated on the basis of the quantity of ZnCI2 recycled so as to maintain a ZnCI2 / lsophytol molar ratio of 0.72 eq.
- Acetylation catalysts Influence on the coloring of tocopheryl acetate (Toco)
- Toco samples are diluted in cyclohexane.
- the solution is introduced into a 10 mm quartz cell.
- the analysis is carried out in the spectral range 400 - 700 nm.
- the trichromatic coordinates are as follows:
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000574095A JP2002526489A (ja) | 1998-09-18 | 1999-09-15 | ビタミンeの製造方法 |
DE69916090T DE69916090T2 (de) | 1998-09-18 | 1999-09-15 | Verfahren zur herstellung des alpha-tocopherol acetats |
AT99942978T ATE263161T1 (de) | 1998-09-18 | 1999-09-15 | Verfahren zur herstellung des alpha-tocopherol acetats |
US09/787,264 US6518439B1 (en) | 1998-09-18 | 1999-09-15 | Method for preparing vitamin e |
AU56286/99A AU5628699A (en) | 1998-09-18 | 1999-09-15 | Method for preparing vitamin e |
EP99942978A EP1114041B1 (fr) | 1998-09-18 | 1999-09-15 | Procede de preparation de l'acetate d'alpha-tocopherol |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9811679A FR2784104B1 (fr) | 1998-09-18 | 1998-09-18 | Procede de preparation de la vitamine e |
FR98/11679 | 1998-09-18 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/787,264 A-371-Of-International US6518439B1 (en) | 1998-09-18 | 1999-09-15 | Method for preparing vitamin e |
US10/323,273 Division US6790967B2 (en) | 1998-09-18 | 2002-12-19 | Process for the preparation of vitamin E |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000017185A1 true WO2000017185A1 (fr) | 2000-03-30 |
Family
ID=9530589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1999/002196 WO2000017185A1 (fr) | 1998-09-18 | 1999-09-15 | Procede de preparation de la vitamine e |
Country Status (9)
Country | Link |
---|---|
US (2) | US6518439B1 (fr) |
EP (1) | EP1114041B1 (fr) |
JP (1) | JP2002526489A (fr) |
CN (1) | CN1141304C (fr) |
AT (1) | ATE263161T1 (fr) |
AU (1) | AU5628699A (fr) |
DE (1) | DE69916090T2 (fr) |
FR (1) | FR2784104B1 (fr) |
WO (1) | WO2000017185A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1334093A1 (fr) * | 2000-10-23 | 2003-08-13 | SK Corporation | Procede de preparation de dl-alpha-tocopherol avec un haut rendement |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1689733B1 (fr) * | 2003-12-05 | 2008-10-15 | DSM IP Assets B.V. | Procede de fabrication de composes aromatiques hydroxyles alcenyles de composes chromans et de leurs derives acyles |
CN1332667C (zh) * | 2004-05-26 | 2007-08-22 | 中国科学院生物物理研究所 | 一种抗帕金森症(pd)复合制剂 |
CN1332666C (zh) * | 2004-05-26 | 2007-08-22 | 中国科学院生物物理研究所 | 一种抗老年痴呆症复合制剂 |
CN101006070B (zh) * | 2004-08-19 | 2012-11-07 | 帝斯曼知识产权资产管理有限公司 | 包含维生素e和维生素e乙酸酯的混合物或产品流的整理方法 |
WO2006018256A2 (fr) * | 2004-08-19 | 2006-02-23 | Dsm Ip Assets B.V. | Procede de rectification de melanges de produits utiles sensibles a l'air et/ou a la temperature a haut point d'ebullition |
CN102294240B (zh) * | 2011-05-07 | 2013-02-13 | 浙江师范大学 | 一种用于TMBQ加氢生产TMHQ的Pd/C催化剂及制备方法 |
CN102295536B (zh) * | 2011-07-14 | 2013-07-24 | 福建省福抗药业股份有限公司 | 一种高含量三甲基氢醌的制备方法 |
CN102336732A (zh) * | 2011-07-14 | 2012-02-01 | 福建省福抗药业股份有限公司 | 一锅法制备维生素e乙酸酯的生产方法 |
JP2013063912A (ja) * | 2011-08-31 | 2013-04-11 | Eisai R & D Management Co Ltd | α−トコフェロールおよび酢酸α−トコフェロールの製造方法 |
CN102351831A (zh) * | 2011-09-09 | 2012-02-15 | 重庆大学 | 一种制备D,L-α-生育酚乙酸酯的方法 |
CN102276572B (zh) * | 2011-09-14 | 2013-03-27 | 重庆大学 | 一种制备维生素e乙酸酯的方法 |
CN111253218A (zh) * | 2019-12-30 | 2020-06-09 | 上虞新和成生物化工有限公司 | 一种2,3,5-三甲基氢醌的合成方法和装置 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2126214A1 (fr) * | 1971-02-25 | 1972-10-06 | Diamond Shamrock Corp | |
JPS5180859A (en) * | 1975-01-11 | 1976-07-15 | Teijin Ltd | Arufua tokofuerooruruino seizoho |
EP0087576A1 (fr) * | 1982-02-03 | 1983-09-07 | BASF Aktiengesellschaft | Procédé pour préparer de l'acétate de tocophérol ou du propionate de tocophérol |
JPS59190987A (ja) * | 1983-04-11 | 1984-10-29 | Mitsui Toatsu Chem Inc | dl−α−トコフエロ−ルの製造方法 |
JPS6054380A (ja) * | 1983-09-05 | 1985-03-28 | Sumitomo Chem Co Ltd | α−トコフエロ−ルの製造法 |
JPS62226976A (ja) * | 1986-03-28 | 1987-10-05 | Eisai Co Ltd | dl−α−トコフエロ−ルの製造方法 |
EP0694541A1 (fr) * | 1994-07-27 | 1996-01-31 | Eisai Co., Ltd. | Procédé de préparation de alpha-tocophérol |
EP0782993A1 (fr) * | 1996-01-05 | 1997-07-09 | F. Hoffmann-La Roche Ag | Procédé pour la production d'alpha-tocophérol en presence d'un catalyseur perfluoroalkylsulfonate |
WO1998021197A2 (fr) * | 1996-11-11 | 1998-05-22 | F. Hoffmann-La Roche Ag | Procede de fabrication de d,1-alpha-tocopherol |
EP0850937A1 (fr) * | 1996-12-23 | 1998-07-01 | Basf Aktiengesellschaft | Procédé pour la préparation d'alpha-tocophérol ou d'acétate d'alpha-tocophérol par réaction de triméthylhydroquinone et phytol ou isophytol avec recyclage d'halogénure de zinc comme catalyseur de condensation |
EP0924208A1 (fr) * | 1997-12-20 | 1999-06-23 | Degussa Aktiengesellschaft | Procédé pour la préparation des esters de l'alpha-tocophérol |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2523494A1 (fr) * | 1982-03-22 | 1983-09-23 | Ferraz & Cie Lucien | Machine a rectifier les collecteurs electriques et analogues |
US4966914A (en) * | 1988-12-15 | 1990-10-30 | E. I. Du Pont De Nemours And Company | Oculoselective beta-blockers as antiglaucoma agents |
US5411969A (en) * | 1993-04-16 | 1995-05-02 | Bristol-Myers Squibb Company | Antihyperlipidemic/antioxidant dihydroquinolines |
US6020505A (en) * | 1994-07-27 | 2000-02-01 | Eisai Co., Ltd. | Process for the preparation of α-tocopherol |
JPH09188673A (ja) * | 1994-07-27 | 1997-07-22 | Eisai Co Ltd | α−トコフェロールの製造方法 |
-
1998
- 1998-09-18 FR FR9811679A patent/FR2784104B1/fr not_active Expired - Fee Related
-
1999
- 1999-09-15 EP EP99942978A patent/EP1114041B1/fr not_active Expired - Lifetime
- 1999-09-15 JP JP2000574095A patent/JP2002526489A/ja not_active Ceased
- 1999-09-15 US US09/787,264 patent/US6518439B1/en not_active Expired - Fee Related
- 1999-09-15 CN CNB998110434A patent/CN1141304C/zh not_active Expired - Fee Related
- 1999-09-15 DE DE69916090T patent/DE69916090T2/de not_active Expired - Lifetime
- 1999-09-15 AT AT99942978T patent/ATE263161T1/de not_active IP Right Cessation
- 1999-09-15 AU AU56286/99A patent/AU5628699A/en not_active Abandoned
- 1999-09-15 WO PCT/FR1999/002196 patent/WO2000017185A1/fr active IP Right Grant
-
2002
- 2002-12-19 US US10/323,273 patent/US6790967B2/en not_active Expired - Fee Related
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2126214A1 (fr) * | 1971-02-25 | 1972-10-06 | Diamond Shamrock Corp | |
JPS5180859A (en) * | 1975-01-11 | 1976-07-15 | Teijin Ltd | Arufua tokofuerooruruino seizoho |
EP0087576A1 (fr) * | 1982-02-03 | 1983-09-07 | BASF Aktiengesellschaft | Procédé pour préparer de l'acétate de tocophérol ou du propionate de tocophérol |
JPS59190987A (ja) * | 1983-04-11 | 1984-10-29 | Mitsui Toatsu Chem Inc | dl−α−トコフエロ−ルの製造方法 |
JPS6054380A (ja) * | 1983-09-05 | 1985-03-28 | Sumitomo Chem Co Ltd | α−トコフエロ−ルの製造法 |
JPS62226976A (ja) * | 1986-03-28 | 1987-10-05 | Eisai Co Ltd | dl−α−トコフエロ−ルの製造方法 |
EP0694541A1 (fr) * | 1994-07-27 | 1996-01-31 | Eisai Co., Ltd. | Procédé de préparation de alpha-tocophérol |
EP0782993A1 (fr) * | 1996-01-05 | 1997-07-09 | F. Hoffmann-La Roche Ag | Procédé pour la production d'alpha-tocophérol en presence d'un catalyseur perfluoroalkylsulfonate |
WO1998021197A2 (fr) * | 1996-11-11 | 1998-05-22 | F. Hoffmann-La Roche Ag | Procede de fabrication de d,1-alpha-tocopherol |
EP0850937A1 (fr) * | 1996-12-23 | 1998-07-01 | Basf Aktiengesellschaft | Procédé pour la préparation d'alpha-tocophérol ou d'acétate d'alpha-tocophérol par réaction de triméthylhydroquinone et phytol ou isophytol avec recyclage d'halogénure de zinc comme catalyseur de condensation |
EP0924208A1 (fr) * | 1997-12-20 | 1999-06-23 | Degussa Aktiengesellschaft | Procédé pour la préparation des esters de l'alpha-tocophérol |
Non-Patent Citations (5)
Title |
---|
CHEMICAL ABSTRACTS, vol. 102, no. 17, 29 April 1985, Columbus, Ohio, US; abstract no. 149553, XP002121808 * |
CHEMICAL ABSTRACTS, vol. 86, no. 13, 28 March 1977, Columbus, Ohio, US; abstract no. 90092, XP002121807 * |
DATABASE WPI Week 8519, Derwent World Patents Index; AN 85-113110, XP002102854 * |
DATABASE WPI Week 8745, Derwent World Patents Index; AN 87-318204, XP002102855 * |
PATENT ABSTRACTS OF JAPAN vol. 009, no. 052 (C - 269) 6 March 1985 (1985-03-06) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1334093A1 (fr) * | 2000-10-23 | 2003-08-13 | SK Corporation | Procede de preparation de dl-alpha-tocopherol avec un haut rendement |
EP1334093A4 (fr) * | 2000-10-23 | 2004-02-04 | Sk Corp | Procede de preparation de dl-alpha-tocopherol avec un haut rendement |
Also Published As
Publication number | Publication date |
---|---|
FR2784104B1 (fr) | 2002-12-27 |
ATE263161T1 (de) | 2004-04-15 |
CN1318064A (zh) | 2001-10-17 |
US6790967B2 (en) | 2004-09-14 |
US20030153772A1 (en) | 2003-08-14 |
DE69916090T2 (de) | 2005-02-17 |
EP1114041B1 (fr) | 2004-03-31 |
AU5628699A (en) | 2000-04-10 |
JP2002526489A (ja) | 2002-08-20 |
EP1114041A1 (fr) | 2001-07-11 |
CN1141304C (zh) | 2004-03-10 |
US6518439B1 (en) | 2003-02-11 |
DE69916090D1 (de) | 2004-05-06 |
FR2784104A1 (fr) | 2000-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1114041B1 (fr) | Procede de preparation de l'acetate d'alpha-tocopherol | |
EP2791098B1 (fr) | Procede de purification de la vanilline par extraction liquide-liquide | |
EP2627645B1 (fr) | Procede de preparation de la 2-hydroxybutyrolactone | |
JP2002502360A (ja) | dlα―トコフェロールまたは酢酸dl―α―トコフェリルの製造方法 | |
CA1169092A (fr) | PROCEDE POUR LA FABRICATION DE L'ACIDE .beta.- HYDROXYBUTYRIQUE ET DE SES OLIGOCONDENSATS | |
EP0210156B1 (fr) | Complexes moléculaires formés d'un dérivé de benzofuranne et de chlorure d'aluminium, leur préparation et leur utilisation | |
EP1345880B1 (fr) | Procede de preparation d'acides carboxyliques par carbonylation au palladium. | |
FR2465752A1 (fr) | Procede de production de 2,2,4-trimethyl-1,2-dihydroquinoleine polymerisee | |
BE1006039A3 (fr) | Decarboxylation des carbonates d'alcoyle en ethers alcoyliques. | |
EP1147077B1 (fr) | Procede de preparation d'azoiminoethers | |
EP4143153B1 (fr) | Procédé de synthèse de diesters d'acide 2-bromoglutarique | |
EP0546930A1 (fr) | Procédé d'obtention d'esters d'aryle par O-déalkylation et applications | |
EP3510016B1 (fr) | Procédé de production d'acide n-boc-2-amino-3,3-diméthylbutyrique | |
EP0478417B1 (fr) | Procédé de synthèse de monohalogénoalkylferrocènes | |
EP0146439B1 (fr) | Procédé de préparation de dérivés acétyléniques, nouveaux dérivés obtenus et leur emploi | |
BE1015196A3 (fr) | Procede de preparation de derives de malondialdehyde. | |
WO2023111488A1 (fr) | Procédé de préparation du propofol | |
EP0179685B1 (fr) | Procédé de préparation d'esters allyliques tertiaires éventuellement halogénés | |
WO1985003301A1 (fr) | Procede de preparation d'aspartyl peptides et nouveaux derives de l'acide aspartique utilisables dans leurs synthese | |
WO2009071799A1 (fr) | Procede de synthese de l'acide 4-benzofurane carboxylique | |
FR2466464A1 (fr) | Procede de preparation de 2-oxo-dihydrobenzo (d) (1,3) oxazines | |
WO2004092151A1 (fr) | PROCEDE DE PREPARATION DU 4,10β-DIACETOXY-2α BENZOYLOXY-5β,20-EPOXY-1,13α-DIHYDROXY-9-OXO-19- NORCYCLOPROPA[G]TAX-11-ENE | |
FR2584395A1 (fr) | Procede de preparation de decabromodiphenylether | |
EP0112785A1 (fr) | Procédé de préparation du dihydro-2,3 diméthyl-2,2 hydroxy-7 benzofuranne | |
WO2004074229A1 (fr) | Procede d’acylation de composes aromatiques en presence d’un catalyseur recyclable |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99811043.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AU BA BB BG BR CA CN CR CU CZ DM EE GD GE HR HU ID IL IN IS JP KP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO RU SG SI SK SL TR TT UA US UZ VN YU ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999942978 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2000 574095 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09787264 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999942978 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999942978 Country of ref document: EP |